Christian Belliard Estevez
Internal Medicine · Bronx, NYNPI 1215136254
Payments from drug & device makers
Across 129 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$642
- Novo Nordisk$535
- Intra-sana Laboratories$342
- Sanofi-aventis U.S. LLC$255
- Exact Sciences$245
- Mannkind Corporation$221
- plus $886 from 12 others
What the payments were for
- Food & beverage$3,113100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 31 | $642 |
| Novo Nordisk | 18 | $535 |
| Intra-sana Laboratories | 6 | $342 |
| Sanofi-aventis U.S. LLC | 12 | $255 |
| Exact Sciences | 7 | $245 |
| Mannkind Corporation | 10 | $221 |
| Boehringer Ingelheim | 9 | $185 |
| Merck | 11 | $161 |
| Dexcom, Inc. | 2 | $114 |
| AstraZeneca | 6 | $93 |
| Novartis | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 2 | $63 |
| Amarin Pharma, Inc. | 3 | $55 |
| GSK | 3 | $51 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| Bayer | 1 | $20 |
| Lilly USA, LLC | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reltone 200 Mg$244
- GLYCATE$244
- Reltone 400 Mg$244
- RYBELSUS$229
- Tavneos$124
How this compares
$3,126 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 92 | $81,824 |
| JardianceEmpagliflozin | 78 | $68,790 |
| TrulicityDulaglutide | 40 | $57,970 |
| EliquisApixaban | 58 | $55,536 |
| KerendiaFinerenone | 53 | $54,228 |
| JanumetSitagliptin Phos/Metformin Hcl | 35 | $40,986 |
| FarxigaDapagliflozin Propanediol | 38 | $32,565 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 131 | $31,285 |
| RybelsusSemaglutide | 15 | $29,207 |
| OzempicSemaglutide | 30 | $27,550 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 44 | $21,980 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 11 | $18,969 |
| XareltoRivaroxaban | 15 | $13,547 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $12,190 |
| Arnuity ElliptaFluticasone Furoate | 62 | $12,141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet | $161 | $122,809127 claims |
| Boehringer IngelheimJardiance, Jentadueto, Tradjenta, Spiriva Respimat | $185 | $93,860123 claims |
| GSKAnoro Ellipta, Arnuity Ellipta, Breo Ellipta, Trelegy Ellipta, Incruse Ellipta | $51 | $58,727164 claims |
| Lilly USA, LLCTrulicity | $15 | $57,97040 claims |
| Novo NordiskRybelsus, Ozempic | $535 | $56,75845 claims |
| BayerKerendia | $20 | $54,22853 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $93 | $44,75458 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Bronx
- Benjamin GartrellBronx$6.3M
- David SteinBronx$2.4M
- Haiying ChengBronx$1.7M
- Jason LeiderBronx$1.4M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.